From F00 l. I think they need to do some more research - nothing about Fragile X, TBI, etc.
2 growing biotech stocks for your portfolio in 2015
By now investors will have come to terms with the fact that in 2014 the gains from the S&P/ASX 200 were nothing short of lacklustre.
Despite the flat result and the less-than-rosy economic outlook for 2015 there are always ‘gems’ to be found on the stock market.
Neuren Pharmaceuticals Ltd
Having gained close to 50% in the last year, Neuren currently trades at 15.5 cents and with a market capitalisation of approximately $250 million. Neuren is hoping to develop a drug to treat Rett syndrome – a disease for which there is currently no cure.
Ready set blast off, page-21
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.47 |
Change
0.080(0.41%) |
Mkt cap ! $2.486B | |||
| Open | High | Low | Value | Volume |
| $19.58 | $19.85 | $19.23 | $9.536M | 488.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1770 | $19.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.49 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.51 |
Change
0.080 ( 0.62 %) |
||||
| Open | High | Low | Volume | ||
| $19.60 | $19.82 | $19.24 | 217738 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| NEU (ASX) Chart |